The member companies of Rx&D invest $1.1 billion per year in innovative research in Canada.
When we talk about me-too drugs, you are talking about generic products. I do not believe that a discovery like insulin would be part of that group.
On October 25th, 2006. See this statement in context.
October 25th, 2006 / 9:55 a.m.
President and Chief Executive Officer, Aeterna Zentaris Inc., Canada's Research-Based Pharmaceutical Companies (Rx&D)
The member companies of Rx&D invest $1.1 billion per year in innovative research in Canada.
When we talk about me-too drugs, you are talking about generic products. I do not believe that a discovery like insulin would be part of that group.
See context to find out what was said next.